ABL Bio Inc. (KOSDAQ:298380)
South Korea
· Delayed Price · Currency is KRW 190,600
-10,400 (-5.17%)
At close: Dec 5, 2025
ABL Bio Revenue
ABL Bio had revenue of 1.44B KRW in the quarter ending September 30, 2025, a decrease of -81.82%. This brings the company's revenue in the last twelve months to 88.44B, up 173.62% year-over-year. In the year 2024, ABL Bio had annual revenue of 33.40B, down -49.04%.
Revenue (ttm)
88.44B
Revenue Growth
+173.62%
P/S Ratio
118.81
Revenue / Employee
867.02M
Employees
102
Market Cap
10.51T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 33.40B | -32.14B | -49.04% |
| Dec 31, 2023 | 65.55B | -1.75B | -2.61% |
| Dec 31, 2022 | 67.30B | 61.97B | 1,162.19% |
| Dec 31, 2021 | 5.33B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition